7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Citrus Flavonoid, Nobiletin, Inhibits Peritoneal Dissemination of Human Gastric Carcinoma in SCID Mice

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The flavonoid nobiletin (5,6,7,8,3′,4′–hexamethoxyflavone), found in Citrus depressa Rutaceae, a popular citrus fruit in Okinawa, Japan, reportedly inhibits the production of pro–matrix metallo–proteinase (proMMP)–l, 3, and 9 in rabbit synovial fibroblasts in vitro. In the present study, we demonstrated the inhibitory effects of nobiletin on the proliferation of the cancer cell line, TMK–1, and its production of MMPs. In the SCID mouse model, we found that nobiletin inhibited the formation of peritoneal dissemination nodules from TMK–1. The enzymatic activity of MMP–9 expressed in culture medium obtained from a co–culture of TMK–1 and mouse fibroblastic cells was inhibited by nobiletin in a concentration–dependent manner. In the SCID mouse model, total weight of dissemination nodules was significantly lower in the treated group compared with the vehicle control group (0.07 g vs. 0.78 g, P=0.0059). The total number of dissemination nodules was also significantly lower than in the vehicle control group (7.5 vs. 69.3/body, P=0.0001). These results suggest that nobiletin may be a candidate anti–metastatic drug for prevention of peritoneal dissemination of gastric cancer.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

            Two cyclooxygenase isozymes catalyze conversion of arachidonic acid to prostaglandin H2: constitutive COX-1 and inducible COX-2. To assess the role of COX-2 in colorectal tumorigenisis, we determined the effects of COX-2 gene (Ptgs2) knockouts and a novel COX-2 inhibitor on Apc delta716 knockout mice, a model of human familial adenomatous polyposis. A Ptgs2 null mutation reduced the number and size of the intestinal polyps dramatically. Furthermore, treating Apc delta716 mice with a novel COX-2 inhibitor reduced the polyp number more significantly than with sulindac, which inhibits both isoenzymes. These results provide direct genetic evidence that COX-2 plays a key role in tumorigenesis and indicate that COX-2-selective inhibitors can be a novel class of therapeutic agents for colorectal polyposis and cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

              Several studies indicate that nonsteroidal anti-inflammatory drugs including indomethacin, aspirin, sulindac, and piroxicam reduce the risk of colon cancer. Furthermore, nonsteroidal anti-inflammatory drugs that inhibit the cyclooxygenase (COX) enzyme were shown to inhibit the development of colon cancer in animal models of carcinogenesis. Non-steroidal anti-inflammatory drugs inhibit the enzymatic activity of both the constitutive (COX-1) and inducible (COX-2) isoforms of COX enzyme. We have investigated the expression of COX-1 and COX-2 polypeptides in human colon cancer tissues using immunohistochemistry. Enhanced COX-2 expression was observed in colon cancer tissues from 15 subjects with clinically diagnosed colorectal cancer. Marked COX-2 expression was observed in cancer cells, inflammatory cells, vascular endothelium, and fibroblasts of the lesional tissues compared with the nonlesional and normal colon tissues. The extent and intensity of the immunoreactive COX-2 in cancer cells was much greater than that of the other cell types. In contrast, the expression of COX-1 polypeptide was weak in both normal and cancerous specimens. These data suggest that the enhanced expression of the COX-2 gene in colon cancer tissues may contribute to the enhanced synthesis of prostaglandin E2 by the colon cancer tissues. Enhanced expression of COX-2 may play a role in the pathogenesis of colon cancer. Furthermore, selective inhibition of COX-2 may prove to be more efficacious in the retardation of colon cancer development.
                Bookmark

                Author and article information

                Journal
                Jpn J Cancer Res
                Jpn. J. Cancer Res
                10.1111/(ISSN)1349-7006a
                CAS
                Japanese Journal of Cancer Research : Gann
                Blackwell Publishing Ltd (Oxford, UK )
                0910-5050
                1876-4673
                December 2001
                : 92
                : 12 ( doiID: 10.1111/cas.2001.92.issue-12 )
                : 1322-1328
                Affiliations
                [ 1 ]Department of Surgery
                [ 2 ]Department of Pathology
                [ 3 ]Department of Otorhinolaryngology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku–ku, Tokyo 160–8582
                [ 4 ]Department of Citriculture, National Institute of Fruit Tree Science, 485–6 Okitsucho, Shimizu–shi, Shizuoka 424–0292
                [ 5 ]Department of Biochemistry and Molecular Biology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432–1 Horinouchi, Hachioji–shi, Tokyo 192–0392
                Author notes
                [*] [* ] To whom correspondence should be addressed. E–mail: otaniy@ 123456sc.itc.keio.ac.jp
                Article
                CAE1322
                10.1111/j.1349-7006.2001.tb02156.x
                5926678
                11749698
                b9ace018-64ef-469e-a88e-5fa295a784c4
                History
                Page count
                References: 36, Pages: 7
                Categories
                Article
                Custom metadata
                2.0
                December 2001
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015

                flavonoid,nobiletin,gastric cancer,peritoneal dissemination,matrix metallo,proteinase

                Comments

                Comment on this article